{"product_id":"the-passmachine-medical-oncology-review-2017","title":"The Passmachine Medical Oncology Review 2017","description":"\u003ch3\u003eThe Passmachine Medical Oncology Review 2017\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 59 videos + 59 pdfs, size: 6.89 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: oncologist\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e1A. Anticancer Therapeutics – Part I.mp4\u003cbr\u003e1A. Anticancer Therapeutics – Part I.pdf\u003cbr\u003e1B. Anticancer Therapeutics – Part II.mp4\u003cbr\u003e1B. Anticancer Therapeutics – Part II.pdf\u003cbr\u003e1C. Anticancer Therapeutics – Part III.mp4\u003cbr\u003e1C. Anticancer Therapeutics – Part III.pdf\u003cbr\u003e1D. Anticancer Therapeutics – Part IV.mp4\u003cbr\u003e1D. Anticancer Therapeutics – Part IV.pdf\u003cbr\u003e2. Clinical Research Methodology _ Ethics.mp4\u003cbr\u003e2. Clinical Research Methodology _ Ethics.pdf\u003cbr\u003e3. Principles of Allied Disciplines.mp4\u003cbr\u003e3. Principles of Allied Disciplines.pdf\u003cbr\u003e4A. Early-Stage Invasive Carcinoma – Part I.mp4\u003cbr\u003e4A. Early-Stage Invasive Carcinoma – Part I.pdf\u003cbr\u003e4B. Early-Stage Invasive Carcinoma – Part II.mp4\u003cbr\u003e4B. Early-Stage Invasive Carcinoma – Part II.pdf\u003cbr\u003e4C. Early-Stage Invasive Carcinoma – Part III.mp4\u003cbr\u003e4C. Early-Stage Invasive Carcinoma – Part III.pdf\u003cbr\u003e5. Less Common Histologies _ Clinical Scenarios.mp4\u003cbr\u003e5. Less Common Histologies _ Clinical Scenarios.pdf\u003cbr\u003e6. Locally Advanced _ Inflammatory Disease _ Locally Recurrent Disease.mp4\u003cbr\u003e6. Locally Advanced _ Inflammatory Disease _ Locally Recurrent Disease.pdf\u003cbr\u003e7A. Metastatic Disease – Part I.mp4\u003cbr\u003e7A. Metastatic Disease – Part I.pdf\u003cbr\u003e7B. Metastatic Disease – Part II.mp4\u003cbr\u003e7B. Metastatic Disease – Part II.pdf\u003cbr\u003e7C. Metastatic Disease – Part III.mp4\u003cbr\u003e7C. Metastatic Disease – Part III.pdf\u003cbr\u003e8. Premalignant Conditions, High-risk Factors _ Carcinoma in Situ.mp4\u003cbr\u003e8. Premalignant Conditions, High-risk Factors _ Carcinoma in Situ.pdf\u003cbr\u003e9. Gastrointestinal – Esophageal _ Gastric Cancer.mp4\u003cbr\u003e9. Gastrointestinal – Esophageal _ Gastric Cancer.pdf\u003cbr\u003e10. Gastrointestinal – Pancreatic _ Anal Cancer.mp4\u003cbr\u003e10. Gastrointestinal – Pancreatic _ Anal Cancer.pdf\u003cbr\u003e11. Gastrointestinal – Hepatocellular _ Biliary-Gallbladder Cancer _ Neuroendocrine Tumors.mp4\u003cbr\u003e11. Gastrointestinal – Hepatocellular _ Biliary-Gallbladder Cancer _ Neuroendocrine Tumors.pdf\u003cbr\u003e12. Gastrointestinal – Colorectal Cancer.mp4\u003cbr\u003e12. Gastrointestinal – Colorectal Cancer.pdf\u003cbr\u003e13. Heritable Cancer Syndromes _ Epidemiology of Cancer.mp4\u003cbr\u003e13. Heritable Cancer Syndromes _ Epidemiology of Cancer.pdf\u003cbr\u003e14. Germ Cell Tumors.mp4\u003cbr\u003e14. Germ Cell Tumors.pdf\u003cbr\u003e15A. Prostate Cancer – Localized Disease _ Locally Advanced Disease.mp4\u003cbr\u003e15A. Prostate Cancer – Localized Disease _ Locally Advanced Disease.pdf\u003cbr\u003e15B. Prostate Cancer – Metastatic Disease.mp4\u003cbr\u003e15B. Prostate Cancer – Metastatic Disease.pdf\u003cbr\u003e15C. Prostate Cancer – Prostate-specific Antigen-only Disease.mp4\u003cbr\u003e15C. Prostate Cancer – Prostate-specific Antigen-only Disease.pdf\u003cbr\u003e16A. Renal Cell Cancer – Localized Disease.mp4\u003cbr\u003e16A. Renal Cell Cancer – Localized Disease.pdf\u003cbr\u003e16B. Renal Cell Cancer – Metastatic Disease _ Rare Renal Tumors.mp4\u003cbr\u003e16B. Renal Cell Cancer – Metastatic Disease _ Rare Renal Tumors.pdf\u003cbr\u003e17A. Urothelial _ Other Genitourinary Cancers – Localized Bladder Cancer.mp4\u003cbr\u003e17A. Urothelial _ Other Genitourinary Cancers – Localized Bladder Cancer.pdf\u003cbr\u003e17B. Urothelial _ Other Genitourinary Cancers – Metastatic Bladder Cancer _ Other Urothelial Cancers.mp4\u003cbr\u003e17B. Urothelial _ Other Genitourinary Cancers – Metastatic Bladder Cancer _ Other Urothelial Cancers.pdf\u003cbr\u003e18. Cancer of the Cervix, Vulva, Vagina _ Other Gynecologic Malignancies.mp4\u003cbr\u003e18. Cancer of the Cervix, Vulva, Vagina _ Other Gynecologic Malignancies.pdf\u003cbr\u003e19A. Ovary Cancer I.mp4\u003cbr\u003e19A. Ovary Cancer I.pdf\u003cbr\u003e19B. Ovary Cancer II.mp4\u003cbr\u003e19B. Ovary Cancer II.pdf\u003cbr\u003e20. Head _ Neck Cancer, Thyroid Cancer, Salivary Gland.mp4\u003cbr\u003e20. Head _ Neck Cancer, Thyroid Cancer, Salivary Gland.pdf\u003cbr\u003e21A. Acute Leukemia _ Myelodysplasia I.mp4\u003cbr\u003e21A. Acute Leukemia _ Myelodysplasia I.pdf\u003cbr\u003e21B. Acute Leukemia _ Myelodysplasia II.mp4\u003cbr\u003e21B. Acute Leukemia _ Myelodysplasia II.pdf\u003cbr\u003e22. Chronic Lymphoproliferative Leukemias.mp4\u003cbr\u003e22. Chronic Lymphoproliferative Leukemias.pdf\u003cbr\u003e23. Chronic Myeloid Leukemia.mp4\u003cbr\u003e23. Chronic Myeloid Leukemia.pdf\u003cbr\u003e24A. Multiple Myeloma _ Plasma Cell Dyscrasias I.mp4\u003cbr\u003e24A. Multiple Myeloma _ Plasma Cell Dyscrasias I.pdf\u003cbr\u003e24B. Multiple Myeloma _ Plasma Cell Dyscrasias II.mp4\u003cbr\u003e24B. Multiple Myeloma _ Plasma Cell Dyscrasias II.pdf\u003cbr\u003e25. Myeloproliferative Neoplasms.mp4\u003cbr\u003e25. Myeloproliferative Neoplasms.pdf\u003cbr\u003e26A. Non-Hodgkin Lymphoma I.mp4\u003cbr\u003e26A. Non-Hodgkin Lymphoma I.pdf\u003cbr\u003e26B. Non-Hodgkin Lymphoma II.mp4\u003cbr\u003e26B. Non-Hodgkin Lymphoma II.pdf\u003cbr\u003e26C. Non-Hodgkin Lymphoma III.mp4\u003cbr\u003e26C. Non-Hodgkin Lymphoma III.pdf\u003cbr\u003e27A. Bone _ Soft Tissue Sarcomas _ Unknown Primary Site I.mp4\u003cbr\u003e27A. Bone _ Soft Tissue Sarcomas _ Unknown Primary Site I.pdf\u003cbr\u003e27B. Unknown Primary Site II.mp4\u003cbr\u003e27B. Unknown Primary Site II.pdf\u003cbr\u003e28. Melanoma _ Other Skin Cancers.mp4\u003cbr\u003e28. Melanoma _ Other Skin Cancers.pdf\u003cbr\u003e29A. Cancer Pain I.mp4\u003cbr\u003e29A. Cancer Pain I.pdf\u003cbr\u003e29B. Cancer Pain II _ Survivorship Issues.mp4\u003cbr\u003e29B. Cancer Pain II _ Survivorship Issues.pdf\u003cbr\u003e30A. Clinical Manifestations of Advanced Cancer _ its Treatment I.mp4\u003cbr\u003e30A. Clinical Manifestations of Advanced Cancer _ its Treatment I.pdf\u003cbr\u003e30B. Clinical Manifestations of Advanced Cancer _ its Treatment II.mp4\u003cbr\u003e30B. Clinical Manifestations of Advanced Cancer _ its Treatment II.pdf\u003cbr\u003e30C. Clinical Manifestations of Advanced Cancer _ its Treatment III.mp4\u003cbr\u003e30C. Clinical Manifestations of Advanced Cancer _ its Treatment III.pdf\u003cbr\u003e31. End-of-Life Issues.mp4\u003cbr\u003e31. End-of-Life Issues.pdf\u003cbr\u003e32. Procedure-related Issues _ Communication.mp4\u003cbr\u003e32. Procedure-related Issues _ Communication.pdf\u003cbr\u003e33A. Non-Small Cell Lung Cancer – Early-Stage Disease.mp4\u003cbr\u003e33A. Non-Small Cell Lung Cancer – Early-Stage Disease.pdf\u003cbr\u003e33B. Non-Small Cell Lung Cancer – Locally Advanced Disease – Pancoast Tumor.mp4\u003cbr\u003e33B. Non-Small Cell Lung Cancer – Locally Advanced Disease – Pancoast Tumor.pdf\u003cbr\u003e33C. Non-Small Cell Lung Cancer – Locally Advanced – Stage IIIA Disease.mp4\u003cbr\u003e33C. Non-Small Cell Lung Cancer – Locally Advanced – Stage IIIA Disease.pdf\u003cbr\u003e33D. Non-Small Cell Lung Cancer – Locally Advanced – Stage IIIB Disease.mp4\u003cbr\u003e33D. Non-Small Cell Lung Cancer – Locally Advanced – Stage IIIB Disease.pdf\u003cbr\u003e33E. Non-Small Cell Lung Cancer – Metastatic Disease – Adenocarcinoma.mp4\u003cbr\u003e33E. Non-Small Cell Lung Cancer – Metastatic Disease – Adenocarcinoma.pdf\u003cbr\u003e33F. Non-Small Cell Lung Cancer – Metastatic Disease – Squamous Cell Carcinoma.mp4\u003cbr\u003e33F. Non-Small Cell Lung Cancer – Metastatic Disease – Squamous Cell Carcinoma.pdf\u003cbr\u003e34. Small Cell Lung Cancer, Mesothelioma _ Thymus Cancer.mp4\u003cbr\u003e34. Small Cell Lung Cancer, Mesothelioma _ Thymus Cancer.pdf\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954481467490,"sku":"MED-AMB04223","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/The-Passmachine-Internal-Medicine-Board-Review-2018-1-1.jpg?v=1779377615","url":"https:\/\/meducourse.com\/products\/the-passmachine-medical-oncology-review-2017","provider":"Meducourse","version":"1.0","type":"link"}